Biosyent investor
WebJun 11, 2024 · A copy of the early warning report will be available under BioSyent’s profile on SEDAR at www.sedar.com, or may be obtained by contacting Ryan Caughey, General Counsel and Corporate Secretary at ... WebBioSyent is continuously looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then managesthese products through the regulatory process and product registration (approval); and once approved, BioSyent markets these products throughout Canada. These …
Biosyent investor
Did you know?
WebApr 9, 2024 · The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, … WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of …
WebMar 24, 2024 · Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product ... http://www.biosyent.com/rx/investors_financials/
WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It … http://www.biosyent.com/rx/investor_facts/
WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd.
WebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr. flowood veterans disability lawyer vimeoWebApr 6, 2024 · BioSyent's mailing address is 170 Attwell Dr Suite 520, ETOBICOKE, ON M9W 5Z5, Canada. The official website for the company is www.biosyent.com. The … flowood surgery centerWebDec 23, 2004 · Globe Investor - The Globe and Mail - Wed Apr 12, 4:02PM CDT. Today, shares of Biosyent Inc opened at $7.45 and closed at $7.70. ... Biosyent Inc is a TSX Drug Specialty & Generic company ... green city growers bostonWebShares of BioSyent are available in the United States on the OTC Pink Marketplace under the trading symbol BIOYF. 2. Looking for general information about your shares? All … flowood sports medicineWebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein ... green city growers cooperativeWebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then … green city grocery storeWebBioSyent Inc. Listed on the TSX Venture Exchange (TSXV: RX) BioSyent is a profitable growth oriented speciality pharmaceutical company which searches the globe to in … flowood storage units